Gregory K. Hinckley's most recent trade in SI-BONE Inc was a trade of 8,675 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SI-BONE Inc | Gregory K. Hinckley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 8,675 | 102,050 (0%) | 0% | 0 | Common Stock | |
| Bio-Rad Laboratories Inc. ... | Gregory K. Hinckley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2025 | 407 | 407 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Gregory K. Hinckley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2025 | 308 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Gregory K. Hinckley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2025 | 308 | 308 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Gregory K. Hinckley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 308 | 308 | - | - | Restricted Stock Units | |
| SI-BONE Inc | Gregory K. Hinckley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 8,791 | 93,375 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | Gregory K. Hinckley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 4,866 | 84,584 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | Gregory K. Hinckley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,324 | 79,718 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | Gregory K. Hinckley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2021 | 6,170 | 3,085 | - | - | Stock Option (Right to Buy) | |
| SI-BONE Inc | Gregory K. Hinckley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.94 per share. | 16 Jun 2021 | 6,170 | 72,573 (0%) | 0% | 5.9 | 36,650 | Common Stock |
| SI-BONE Inc | Gregory K. Hinckley | Director | Sale of securities on an exchange or to another person at price $ 31.46 per share. | 16 Jun 2021 | 1,179 | 71,394 (0%) | 0% | 31.5 | 37,091 | Common Stock |
| SI-BONE Inc | Gregory K. Hinckley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 3,848 | 66,403 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | Gregory K. Hinckley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2020 | 12,967 | 9,255 | - | - | Stock Option (Right to Buy) | |
| SI-BONE Inc | Gregory K. Hinckley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.94 per share. | 26 Aug 2020 | 12,967 | 62,555 (0%) | 0% | 5.9 | 77,024 | Common Stock |